ROYCE & ASSOCIATES LP - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 272 filers reported holding BLUEBIRD BIO INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2020$324,000
-78.8%
6,000
-76.0%
0.00%
-82.4%
Q2 2020$1,526,000
+74.8%
25,000
+31.6%
0.02%
+41.7%
Q1 2020$873,000
-47.6%
19,0000.0%0.01%
-20.0%
Q4 2019$1,667,000
+14.2%
19,000
+90.0%
0.02%
+50.0%
Q3 2018$1,460,000
-7.0%
10,0000.0%0.01%
-9.1%
Q2 2018$1,570,00010,0000.01%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,550,000$7,518,0001.50%
Birchview Capital, LP 84,000$407,0000.29%
PDT Partners, LLC 519,485$2,520,0000.22%
OCCUDO QUANTITATIVE STRATEGIES LP 320,922$1,556,0000.13%
Virtus ETF Advisers LLC 40,607$197,0000.09%
Baker Brothers Advisors 2,499,715$12,124,0000.07%
Green Alpha Advisors, LLC 14,660$71,0000.05%
Quinn Opportunity Partners LLC 140,824$683,0000.03%
Rafferty Asset Management, LLC 979,122$4,749,0000.03%
Inspire Investing, LLC 48,724$236,0000.03%
View complete list of BLUEBIRD BIO INC shareholders